Driehaus Capital Management LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 938206
Chicago, IL
Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$41,932,573
-$16,151,658 QoQ
Shares Held
78,094
-29.6% QoQ
Ownership
0.338%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#54
of 411 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Driehaus Capital Management LLC holds $3,602,052,293 across 59 Biotechnology names. MDGL ranks #19 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
6,845,276 | $322,001,783 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
959,048 | $321,079,679 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
4,418,557 | $266,704,100 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
2,799,166 | $248,509,957 | |
| 5 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
6,463,551 | $241,866,078 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
1,740,101 | $230,963,605 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
4,728,623 | $192,123,952 | |
| 8 | SEPN |
Septerna, Inc.
|
4,433,058 | $148,463,112 |
All Filings in MDGL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,932,573 | 78,094 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $58,084,231 | 110,960 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $65,027,578 | 111,666 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $53,192,634 | 115,974 | Shares | Sole | 2025-11-14 | |
| 2024-03-31 | $13,541,331 | 50,709 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||